CME Group Q2 2026 Revenue Tops Estimates
CME Group reported Q2 2026 results exceeding revenue expectations, with revenue flat year-on-year at $1.71 billion. Non-GAAP EPS of $2.99 was 2.8% above analyst consensus.
Key Numbers
Financial derivatives exchange CME Group (NASDAQ:CME) reported Q2 2026 results that topped market revenue expectations. Revenue came in at $1.71 billion, flat compared to the same quarter last year, while non-GAAP earnings per share of $2.99 exceeded analyst consensus by 2.8%.
Key Financial Results
| Metric | Q2 2026 | Year-over-Year Change |
|---|---|---|
| Revenue | $1.71 billion | Flat (0%) |
| Non-GAAP EPS | $2.99 | 2.8% above consensus |
Highlights from the Report
No additional commentary from the company was provided regarding operational performance or contributing factors.
Forward Guidance
CME Group did not provide official guidance for the upcoming quarter or fiscal year.
Stock Impact
No details on stock price reaction were included in the report.
What This Means for Investors
CME Group beat revenue and earnings expectations, indicating stable performance amid a volatile economic environment. However, the flat year-over-year revenue warrants monitoring of future growth.
Frequently Asked Questions
Found this useful? Share it